Calgary – October 2, 2026 -- Canadian Pacific Kansas City (TSX: CP) (NYSE: CP) moved 5.45 million metric tonnes (MMT) and 56,560 combined carloads of grain and grain products across Canada and the United States in September 2026, setting new monthly and third-quarter records that surpass marks previously set in 2020.

Canadian grain volumes hit 2.94 MMT in September, a second consecutive monthly record

CPKC moved 2.94 MMT and 30,324 carloads of grain and grain products in Canada in September 2026, marking the second record month in a row to open the 2026-2027 crop year. The July-September 2026 quarter also set a third-quarter record for both carloads and metric tonnes in Canadian grain.

Boca Raton, Fla. – October 02, 2026 -- Florida Atlantic University and Blue Ops, the maritime division of Red Cat Holdings, Inc. (Nasdaq: RCAT), have signed a strategic partnership placing uncrewed maritime systems operations at FAU's Harbor Branch Oceanographic Institute in Fort Pierce.

Blue Ops gains a 144-acre deep-water testing site for uncrewed surface vessels

The agreement grants Blue Ops access to Harbor Branch's secure, 144-acre deep-water port, waterfront infrastructure and marine engineering staff to develop, test and evaluate uncrewed surface vessels, mission systems and open architectures. Activities will include engineering, land- and water-based demonstrations, personnel training, and equipment maintenance and support.

Washington – October 02, 2026 -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) is presenting three new data sets on its monoclonal antibody imsidolimab at the European Academy of Dermatology and Venereology (EADV) Annual Meeting in Vienna, Austria, running September 30 through October 3, 2026.

Vanda shows imsidolimab cuts neutrophil levels rapidly in GPP patients

Poster P1769 (Abstract AS-4323) reports a rapid reduction in neutrophils and the neutrophil percentage-to-albumin ratio following imsidolimab treatment in patients with generalized pustular psoriasis (GPP), a rare orphan skin condition.

Immunogenicity data on imsidolimab presented in separate poster

A second poster, P1784 (Abstract AS-2420), details the immunogenicity profile of imsidolimab in GPP patients.

Parsippany, N.J. – October 02, 2026 -- GAF, North America's largest roofing and waterproofing manufacturer, has expanded its partnership with the DoW SkillBridge program to offer a no-cost, six-month manufacturing training track for transitioning service members.

Manufacturers face a 3.8 million worker gap by 2033

The expansion responds to a labor shortage that Deloitte and The Manufacturing Institute project could leave nearly half of 3.8 million U.S. manufacturing positions unfilled by 2033, with industrial maintenance technicians among the highest-demand roles.

Austin – October 02, 2026 -- Oracle has committed to subscribing to a portion of electricity generated by the Point Beach Nuclear Plant in Wisconsin, a move expected to save utility customers approximately $300 million in fuel costs. The commitment is designed to shield more than 1 million Wisconsin utility customers from the plant's rising operating costs while preserving carbon-free baseload power for the state grid.

Oracle absorbs rising nuclear fuel costs to protect household electricity bills

Point Beach has supplied dependable, carbon-free power to Wisconsin for more than 50 years. By subscribing to a share of the plant's output, Oracle intends to cover increases in fuel costs that would otherwise be passed on to ratepayers, according to Mahesh Thiagarajan, executive vice president of Oracle Cloud Infrastructure.

Irvine, Calif. – October 02, 2026 -- MobileX has appointed Raju Datla as Chief Financial Officer, bringing more than 25 years of telecom, infrastructure and capital markets experience to the wireless carrier as it scales distribution and its AI-driven service platform.

Datla joins from RedCloud Holdings after leading its global finance and capital markets strategy

Datla most recently served as CFO of Nasdaq-listed RedCloud Holdings (NASDAQ: RCT), overseeing finance, capital markets and the financial execution of the company's global expansion. He previously held the Chief Strategy Officer role at Tillman Fiber and was CFO and co-founder of NxtGen Datacenter & Cloud Technologies.

San Francisco – October 02, 2026 -- Supabase has raised $150 million in new funding led by GIC, with Alphabet's independent growth fund CapitalG, IronArc, and SquarePeg also participating, just four months after closing a $500 million Series F round. Alongside the raise, the open source Postgres development platform announced it is acquiring Turso, a database platform built to handle high-volume provisioning for agentic workloads.

Supabase now adds 1 million users and 4 million databases every month

Seventy percent of those new databases are created by agents or AI-driven tools rather than human developers, the company said. The figure follows a 600% year-over-year increase in database creation reported in June, when agent-driven deployments had already become the majority on the platform.

Stamford, Connecticut – October 02, 2026 -- Steward Partners placed three senior executives as finalists in the 2026 Wealth Management Industry Awards, drawing national attention across leadership, compliance and M&A categories in a single cycle.

Three executives earn simultaneous finalist status across distinct disciplines

CEO Jim Gold was named a finalist for CEO of the Year among firms managing more than $25 billion in assets. Chief Compliance Officer Rob Guldner was recognized as a finalist for CCO of the Year, while Scott Danner earned a finalist nod for M&A Leader of the Year.

Ashland, Missouri – October 02, 2026 -- ABK Biomedical Inc. has launched construction of a commercial-scale manufacturing facility at Cartwright Business Park in Ashland, Missouri, designed to produce its Eye90 microspheres for liver cancer treatment. The groundbreaking, attended by Missouri Governor Mike Kehoe, follows the company's April announcement selecting Ashland for its long-term U.S. manufacturing base.

Facility targets commercial-scale output of yttrium-90 radioembolization device

The planned Good Manufacturing Practice (GMP) facility will be built for commercial-scale production of Eye90 microspheres, a clinical-stage yttrium-90 radioembolization device still under development for liver cancer treatment. The devices remain investigational and are not approved for use outside authorized clinical trials.

San Francisco – October 02, 2026 -- Constructor, a product discovery platform for ecommerce, has won the "Agentic Achievement" category at the MACH Alliance's 2026 MACH Impact Awards, citing a 900% year-over-year increase in companies deploying its conversational AI agents.

Retailers report measurable gains from agent deployments

Across customer deployments, Constructor's agentic technology has driven a 57% reduction in support requests, more than double the conversion rate versus standard search, 52% higher add-to-cart rates and 56% higher purchase rates among shoppers using an agent, according to the company.